glp-1 vs gip and in Type 1 Diabetes Therapy: A Time for Reappraisal? The pleiotropic effects of GLP-1

Description: DLE technology employs a proprietary, dry-cell process that prevents degradation of the GHK-Cu peptides during lipid encapsulation

In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes

This expensive treatment can boost a persons energy and has several benefits

This treatment method helps the nutrients bypass the digestive system, allowing for their efficient absorption by the body

Com rpida absoro devido sua forma lquida, facilita a ingesto e o aproveitamento pelo organismo

Primary headaches are not caused by an underlying medical condition